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Investigating the impact of the diseases of despair in Appalachia 
Abstract 
Introduction: Appalachia is one of the regions most significantly impacted by the opioid crisis. This study 
investigated mortality due to diseases of despair within the Appalachian Region, with an additional focus 
on deaths attributable to opioid overdose. 
Methods: Diseases of despair include: alcohol, prescription drug and illegal drug overdose, suicide, and 
alcoholic liver disease/cirrhosis of the liver. Mortality data from the National Center for Health Statistics 
(NCHS) National Vital Statistics System (NVSS) Multiple Cause of Death database were analyzed for this 
study, focusing on individuals aged 15–64. 
Results: Over the past two decades, the mortality rate due to diseases of despair has been increasing 
across the United States, but the gap has widened between the Appalachian Region and the rest of the 
nation. In 2017, the combined diseases of despair mortality rate was 45% higher in the Appalachian 
Region than the non-Appalachian United States. When looking at just overdose mortality, this disparity 
grows to 65% higher in the Appalachian Region. Within the Appalachian region disparities are most 
notable in the Central and North Central Appalachian subregions, among males, and among individuals 
age 45 to 54. 
Discussion: These findings document the scale and scope of the problem in Appalachia and highlight the 
need for additional research and discussion in terms of effective interventions, policies, and strategies to 
address these diseases of despair. Over the past two decades, mortality from overdose, suicide, and 
alcoholic liver diseases/cirrhosis has increased across the United States, but the disparity between 
Appalachia and the non-Appalachian U.S. continues to grow. 
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INTRODUCTION  
 
he Appalachian Region is a 205,000-square-mile region that spans from 
southern New York to northern Mississippi, includes 420 counties and 8 
independent cities in 13 states, and has a population of 25 million people 
(Figure 1).1 Appalachia lags behind the rest of the nation in educational 
attainment, economic development, and health outcomes.2,3 Appalachia’s 
median household income is 83% of the U.S. average, and the region’s poverty 
rate is 16%.2,4 Certain Appalachian subregions experience greater disparities 
than others; for example, labor force participation, household income, and 
bachelor’s degree attainment are lowest in Central Appalachia.2,4–6  A number of 
studies have shown that the residents of the Appalachian Region experience 
significant health disparities compared to the rest of the nation.3,7–10  
 
Figure 1. Map of the Appalachian Region 
Research conducted by Case and Deaton has demonstrated increasing morbidity 
and mortality from three main causes—alcohol, prescription drug and illegal 
drug overdose; suicide; and alcoholic liver disease/cirrhosis of the liver—which 
have been referred to collectively as “diseases of despair.”11 The rise in overdose 
mortality described by Case and Deaton was driven by the opioid crisis in the 
U.S. According to data from the Centers for Disease Control and Prevention 
(CDC), in 2017, the number of overdose deaths involving opioids was six times 
T 
9
Meit et al.: Diseases of despair in Appalachia
Published by the University of Kentucky, 2019
 
 
 
higher than in 1999.12 Socioeconomic factors, including education, employment, 
and income, are potential factors influencing the growing opioid crisis in the U.S. 
This study investigated mortality due to diseases of despair within the 
Appalachian Region, with an additional focus on deaths attributable to opioid 
overdose.  
METHODS  
 
This study aimed to detect differences in the mortality rates from diseases of 
despair between the Appalachian Region and the non-Appalachian U.S. (the rest 
of the country, excluding Appalachia), in addition to differences by age groups 
and gender. Appalachian rates were further analyzed by subregion, county 
economic status, and levels of rurality. Appalachian subregions, as defined by 
the Appalachian Regional Commission (ARC), represent contiguous geographies 
of relatively homogeneous characteristics (topography, demographics, 
economics, and transportation) and include: Northern, North Central, Central, 
South Central, and Southern Appalachia. ARC also provides county-level 
economic classifications based on an index of three economic indicators (3-year 
unemployment rate, per capita market income, and poverty rate). Counties are 
designated based on the index as distressed, at-risk, transitional, competitive, 
or attainment.13 Lastly, ARC designations for rurality were used for these 
analyses. These designations of large metro, small metro, nonmetro adjacent to 
large metros, nonmetro counties adjacent to small metros, and rural counties 
are based on a simplification of the UDSA’s Economic Research Services (ERS) 
2013 Urban Influence Codes (UIC).14 
The majority of the findings presented are from 2015 mortality data from the 
National Center for Health Statistics (NCHS) National Vital Statistics System 
(NVSS) Multiple Cause of Death database, accessed through the CDC Wide-
ranging Online Data for Epidemiologic Research (CDC WONDER).15 Select 
findings include data through 2017. The Multiple Cause of Death database 
provides the underlying cause-of-death, as well as up to 20 additional multiple 
causes, as reported on an individual’s death certificate by a physician, coroner, 
and/or medical examiner.16 Deaths are coded to the International Classification 
of Disease Tenth Revision (ICD-10) codes.  
These analyses included the ICD-10 codes referenced by Case and Deaton, 
reflecting the underlying cause of death from each of the three diseases of 
despair: alcohol, prescription drug and illegal drug overdose (X40–X45, Y10–Y15, 
Y45–Y49); suicide (Y87.0, X60–X84); and alcoholic liver disease/cirrhosis of the 
liver (K70, K73–K74).11 Multiple cause-of-death ICD-10 codes (T40.0, T40.1, 
T40.2, T40.3, T40.4, T40.6) that specify the type of drug causing the overdose 
10
Journal of Appalachian Health, Vol. 1 [2019], Iss. 2, Art. 2
https://uknowledge.uky.edu/jah/vol1/iss2/2
DOI: https://doi.org/10.13023/jah.0102.02
 
 
 
were used to determine the percentage of alcohol, prescription drug and illegal 
drug overdose deaths attributed to opioids.17   
The findings present age-adjusted mortality rates for the population aged 15 to 
64. Additional analyses provide a more granular focus on mortality rates by age 
group (10-year increments between ages 15 and 64). Statistical significance was 
assessed at the 0.05 level using two-sided significance tests (z-tests).  
RESULTS 
 
Over the past 2 decades, the mortality rate due to diseases of despair has been 
increasing across the U.S. While the non-Appalachian U.S. has seen a rise in 
these deaths, the gap has widened between the Appalachian Region and the rest 
of the nation. As shown in Figure 2, the combined diseases of despair mortality 
rate in Appalachia and the non-Appalachian U.S. were nearly identical in 1999. 
By 2009, the mortality rate in the Appalachian Region was 24% higher than the 
non-Appalachian U.S., and by 2017, this difference had grown to 45%. Between 
2009 and 2017, the rate in Appalachia has nearly tripled, showing the increasing 
burden associated with these diseases of despair.  
 
Figure 2. Annual mortality rates attributable to diseases of despair, ages 
15–64, by region (1999–2017)*‡ 
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.  
*In all years except 1999, the Appalachian rate is significantly different from the non-
Appalachian U.S. rate, p ≤0.05 
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and 
Prevention, National Center for Health Statistics.  
Accessed at http://wonder.cdc.gov/mcd-icd10.html 
 
As shown in Figure 3, the mortality rate in 2017 for the combined diseases of 
despair among those aged 15 to 64 years was 82.5 deaths per 100,000 
population, compared to 57.0 deaths per 100,000 population for the non-
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Appalachian U.S. Among the three causes of death (overdose, suicide, and 
alcoholic liver disease/cirrhosis), the disparity between Appalachia and the non-
Appalachian U.S. was greatest for overdose deaths. In 2017, the overdose 
mortality rate was 65% higher in Appalachia than in the non-Appalachian U.S. 
(48.3 deaths per 100,000 population in Appalachia compared to 29.2 deaths per 
100,000 population in the rest of the U.S.)  The suicide mortality rate was 30% 
higher in Appalachia, and the alcoholic liver disease/cirrhosis mortality rate was 
10% higher.  
 
Figure 3. Diseases of despair mortality rates, ages 15–64, by disease and 
region (2017)*‡ 
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.  
*For all diseases, the Appalachian rate is significantly different from the non-Appalachian U.S. 
rate, p ≤0.05  
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and 
Prevention, National Center for Health Statistics. Accessed at http://wonder.cdc.gov/mcd-
icd10.html 
 
The remaining findings are based on 2015 mortality data. As shown in Table 1, 
within Appalachia, males were more likely than females to die from overdose, 
suicide, and alcoholic liver disease/cirrhosis. Among males, the mortality rate 
for the diseases of despair was 92.7 deaths per 100,000, compared to 41.8 
deaths per 100,000 for females. Within Appalachia, individuals aged 45 to 54 
had the highest mortality rate from the combined diseases of despair in 2015, at 
89.0 deaths per 100,000 population.  
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Certain subregions of Appalachia face a notable disparity in mortality from 
overdose, suicide, and alcoholic liver disease/cirrhosis. The mortality rates due 
to the combined diseases of despair were highest in Central and North Central 
Appalachia, with rates of 94.4 deaths per 100,000 population and 88.6 deaths 
per 100,000, respectively. In comparison, the mortality rates in Northern, South 
Central, and Southern Appalachia were 69.1, 65.1, and 52.3 deaths per 100,000, 
respectively.  
Mortality rates also differed by county economic status. For the combined 
diseases of despair, the mortality rate was highest for distressed counties, at 
83.6 deaths per 100,000 population, compared to 47.2 deaths per 100,000 
population for attainment counties. Competitive counties had the second highest 
mortality rate for the combined diseases of despair (73.1 deaths per 100,000 
population.)  
For the combined diseases of despair, rural counties had the highest mortality 
rate at 70.5 deaths per 100,000, compared to 63.2 deaths per 100,000 for large 
metro counties. 
Overdose Deaths. Overdose deaths have become increasingly common over the 
past decade, largely due to the opioid crisis, which has greatly impacted 
Appalachia. In the Appalachian Region in 2015, there were 5594 overdose deaths 
among those aged 15 to 64 years, and of these, 69% were caused by opioids 
(opium, heroin, methadone, other opioids and synthetic narcotics). Overdose 
mortality was 34% higher in economically distressed counties than economically 
nondistressed (attainment, competitive, transitional, and at-risk) counties. 
When comparing metro (large metro and small metro) and nonmetro (nonmetro, 
adjacent large metro; nonmetro, adjacent small metro; and rural) counties, the 
difference was less notable—the overdose mortality rate in metro counties was 
6% higher than the rate in nonmetro counties.  
Overdose mortality significantly impacts Appalachian adults between the ages of 
25 and 54. Among males, the burden in Appalachia was the greatest among 
those aged 25 to 34 years (61.9 deaths per 100,000 population) and 35 to 44 
years (61.0 deaths per 100,000 population). These age groups also experienced 
the highest mortality rates in the non-Appalachian U.S., though large disparities 
were observed when comparing Appalachia to the non-Appalachian U.S. 
Specifically, the overdose mortality rate was 78% higher among those ages 35 to 
44 years and 72% higher among those aged 25 to 34 years in Appalachia than 
the non-Appalachian U.S. While the overall burden was lower among females 
than males, the disparity between Appalachia and the non-Appalachian U.S. was 
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Table 1. Diseases of Despair mortality rates, ages 15–64 (2015)‡  
 Overdose Suicide Alcoholic 
liver 
disease/ 
cirrhosis  
Combined 
Despair 
Deaths 
Region     
 Appalachia  35.4 19.8 11.4 66.6 
 Non-Appalachian U.S. 21.5 16.5 10.6 48.6 
Appalachian Subregion     
Northern 40.2 19.7 9.3 69.1 
North Central  56.3 19.4 11.3 88.6 
Central  54.9 23.3 16.2 94.4 
South Central  30.7 21.1 13.3 65.1 
Southern  22.7 18.5 11.0 52.3 
Economic Status in 
Appalachia  
    
Distressed 46.2 22.1 15.4 83.6 
Non-Distressed     
At-Risk 33.1 22.9 15.2 71.2 
Transitional 33.7 19.4 10.7 63.7 
Competitive  45.8 17.5 9.9 73.1 
Attainment   26.4 15.2 -- 47.2 
Rurality (within Appalachia)       
Large Metro 37.2 17.2 8.8 63.2 
Small Metro  35.5 19.8 12.3 67.5 
Nonmetro, adjacent Large 
Metro   
33.6 21.1 11.9 66.7 
Nonmetro, adj Small 
Metro 
32.4 22.4 12.1 66.9 
Rural  36.2 21.2 13.2 70.5 
Gender (within Appalachia)      
Male 45.1 31.1 16.0 92.2 
Female 25.6 8.5 7.0 41.1 
Age Group (within 
Appalachia)  
    
15–24 12.3 12.6 -- 24.9 
25–34 44.5 19.4 1.7 65.7 
35–44 47.8 21.9 8.3 78.0 
45–54 42.7 24.5 21.8 89.0 
55–64 23.2 20.7 34.5 78.4 
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.  
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and Prevention, 
National Center for Health Statistics.  
Accessed at http://wonder.cdc.gov/mcd-icd10.html 
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greater for females than for males. Among females, the burden in Appalachia 
was the greatest among those aged 45 to 54 years (35.8 deaths per 100,000 
population) and 35 to 44 years (34.7 deaths per 100,000 population). The 
overdose mortality rate for Appalachian females ages 35 to 44 was more than 
double the rate for females in the non-Appalachian U.S., and among those aged 
25 to 34 years, the Appalachian rate was 92% higher.  
As shown in Table 2, states within Appalachia differ in terms of the burden of 
overdose mortality, and also in the percentage of overdose deaths that were 
opioid-related. West Virginia had both the highest overdose mortality rate (59.7 
deaths per 100,000) and the largest percentage of deaths attributed to opioids, 
at 88%. In contrast, Appalachian Mississippi had an overdose mortality rate of 
12.9 deaths per 100,000, of which only 34% were caused by opioids. The greatest 
burden from overdose is located within the states of Central and North Central 
Appalachia, specifically, West Virginia, Appalachian Kentucky, and Appalachian 
Ohio.   
LIMITATIONS  
There are several limitations to this study. First, while we highlight the 
significant increase in overdose deaths between 2015 and 2017, the analyses 
presented for subgroups, including age, gender, economic status, and rurality, 
are based on 2015 mortality data. Due to the rapidly evolving nature of the opioid 
crisis in the U.S., some of these differences have likely changed since 2015. 
Secondly, because we conducted analyses for the diseases of despair 
individually, suicides that are attributable to opioids are not included in the 
overdose category. Finally, the data on opioid-related overdoses are based on 
death certificate reporting, and there are known variations by state in terms of 
the quality of this data.  
DISCUSSION 
These findings document the scale and scope of the problem in Appalachia and 
highlight the need for additional research and discussion in terms of effective 
interventions, policies, and strategies to address these diseases of despair. Over 
the past two decades, mortality from overdose, suicide, and alcoholic liver 
diseases/cirrhosis has increased across the U.S., but the disparity between 
Appalachia and the non-Appalachian U.S. continues to grow. Within Appalachia, 
the burden is concentrated within the Central and North Central subregions, 
where the majority of economically distressed counties are located. Economic 
development strategies and interventions that address other underlying 
contributors to the diseases of despair, in addition to increased access to 
treatment services, prevention, and overdose medications, may be important 
considerations in addressing this problem.  
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Table 2.  Overdose and opioid-related overdose mortality rates, ages 15–
64, by state^ (2015)‡     
 Overdose Opioid-related 
Overdose 
Percent Opioid-
related (%) 
Alabama 24.7 * 10.8 * 44  
Georgia 19.8  14.4  73  
Kentucky 52.1 * 38.5 * 74  
Maryland 48.4 * 41.4 * 86  
Mississippi 12.9 * 4.4 † 34  
New York 24.3  17.2 * 71  
North Carolina 31.7 * 25.2 * 79  
Ohio 49.1 * 40.5 * 82  
Pennsylvania 42.0 * 24.7 * 59  
South Carolina 30.8 * 22.4 * 73  
Tennessee 33.9 * 24.0 * 71  
Virginia 26.1  19.6 * 75  
West Virginia 59.7 * 52.8 * 88  
Appalachia  35.4 * 24.6 * 69  
Non-Appalachian 
U.S. 
21.5  16.5  64  
       
^For states within Appalachia, only the mortality rate for the Appalachian counties is shown.  
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.  
*Mortality rate is significantly different than the non-Appalachian U.S. rate for the same 
overdose category, p ≤0.05 
†Due to small number of deaths, opioid mortality rate is unreliable and not age adjusted.   
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and 
Prevention, National Center for Health Statistics.  
Accessed at http://wonder.cdc.gov/mcd-icd10.html 
 
The rise in opioid overdoses over the past several years has contributed to some 
of the recent increases in diseases of despair. The states with the highest 
mortality from overdose in the Appalachian Region are the ones most 
significantly impacted by the opioid crisis, as shown by the large percentage of 
overdose deaths attributed to opioids. When comparing Appalachia to the non-
Appalachian U.S., the most notable disparities in overdose deaths existed for the 
group aged 25–44 years. Young adults in Appalachia are considerably more likely 
to die from an overdose than similar-aged adults in the rest of the U.S., which 
has significant implications, particularly in terms of economic development, as 
individuals in their prime working years are most impacted.   
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The 2017 data presented shows the rapid increase in overdose deaths due to the 
more powerful synthetic opioids, such as fentanyl; however, these rates have 
likely continued to rise, and the burden within the Appalachian Region is likely 
greater than described in these findings.  It is critical to continue to track trends 
in diseases of despair, and particularly opioid-related mortality, to assess the 
growing burden related to fentanyl and other synthetic opioids.  
SUMMARY BOX 
What is already known about this topic? Work conducted by Case and Deaton (2015) 
demonstrated disparities in mortality resulting from overdose, suicide, and alcoholic liver 
disease among Caucasian working age adults, collectively termed diseases or deaths of 
despair.  
What is added by this report? The work described in this paper expands upon that of Case 
and Deaton by providing a focused exploration of diseases of despair within the Appalachian 
region.  Findings confirm those of Case and Deaton and provide evidence of disparities 
focused most prominently within the Central and North Central Appalachian subregions.  
What are the implications for public health practice, policy, and research? Beyond 
direct implications related to greater mortality burden within the population of working age 
adults in the Central and North Central Appalachian subregions, diseases of despair have 
cascading impacts on regional economic development, children’s health and well-being, and 
social support systems, among others.  Increasing access to treatment services, harm 
reduction programs and prevention initiatives will benefit individuals with substance use 
disorder and provide broader community benefit as rates of substance misuse and overdose 
decline. More broadly, understanding differences in mortality rates at the subregion and 
population group levels support resource allocation and response efforts.   
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